idal ▁ide ation ▁and ▁behaviour ▁in ▁patients ▁under ▁ 1 8 . ▁ ▁An ▁internal ▁Smith K line ▁Be ech am ▁document ▁said ▁in ▁ 1 9 9 8 , ▁about ▁with h eld ▁data ▁from ▁two ▁G SK ▁studies : ▁" It ▁would ▁be ▁commer cially ▁un accept able ▁to ▁include ▁a ▁statement ▁that ▁[ ped iat ric ] ▁effic acy ▁had ▁not ▁been ▁demonstrated , ▁as ▁this ▁would ▁und erm ine ▁the ▁profile ▁of ▁par ox et ine ." ▁The ▁company ▁g host w rote ▁an ▁article , ▁published ▁in ▁ 2 0 0 1 , ▁in ▁the ▁Journal ▁of ▁the ▁American ▁Academy ▁of ▁Child ▁and ▁Ad oles cent ▁Psych iat ry , ▁that ▁mis report ed ▁the ▁results ▁of ▁one ▁of ▁its ▁clin ical ▁tri als , ▁Study ▁ 3 2 9 . ▁The ▁article ▁concluded ▁that ▁P ax il ▁was ▁" gener ally ▁well ▁toler ated ▁and ▁effective ▁for ▁major ▁de pression ▁in ▁ad oles c ents ." ▁The ▁supp ression ▁of ▁the ▁research ▁find ings ▁is ▁the ▁subject ▁of ▁Side ▁Effect s ▁( 2 0 0 8 ) ▁by ▁Al ison ▁Bass . ▁ ▁For ▁ 1 0 ▁years ▁G SK ▁market ed ▁P ax il ▁as ▁non - hab it ▁forming . ▁In ▁ 2 0 0 1 , ▁ 3 5 ▁patients ▁file d ▁a ▁class - action ▁suit ▁alleg ing ▁they ▁had ▁suffered ▁withdraw al ▁sympt oms , ▁and ▁in ▁ 2 0 0 2 , ▁a ▁Los ▁Angeles ▁court ▁issued ▁an ▁inj unction ▁prevent